Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Trials
Collaboration
Funding
Collaboration
National hepatitis C elimination program represents an historic opportunity, according to White House
The Biden-Harris administration proposes a five-year program to expand screening, testing, treatment, and prevention of hepatitis C, focusing on high-risk populations.
March 14, 2023
Sophia Genetics partnering with Agilent Technologies to offer cancer analysis solution
Through the partnership, the Sophia DDM Platform will be integrated with Agilent’s research-use-only SureSelect Cancer Comprehensive Genomic Profiling (CGP) Assay Kit.
March 14, 2023
Techcyte, Mayo Clinic to collaborate on algorithms for pathology platform
Techcyte’s Clinical Pathology AI Platform, which is CE-marked under IVDR and designated for research use only in the U.S., imports digital images of liquid-based samples from whole-slide scanners.
March 14, 2023
Illumina, Myriad Genetics provide U.S. access to HRD research test
The expanded partnership establishes a companion diagnostic (CDx) testing alliance for the pharmaceutical industry, which will enable more clinical research for gene-based, targeted therapies, the firms said.
March 6, 2023
Synergy Laboratories taps Sophia Genetics technology for cancer profiling
Synergy Oncology will pair its laboratory technologies with the Sophia DDM for Hereditary Cancers Solution for tumor profiling.
February 28, 2023
Beckman Coulter, Sciex collaborate on high-throughput screening workflows
The Sciex Echo MS system, which leverages acoustic ejection mass spectrometry, is now compatible with the Biomek and Echo liquid handler lines from Beckman Coulter Life Sciences.
February 27, 2023
Most Popular
Quest launches long-COVID testing panels for consumers
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for millions of dollars in unnecessary urinalysis testing
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
LumiraDx Q4 revenues drop 65% on lower COVID-19 testing
Patients prefer immediate test results, even when the news is bad
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
Roche, Janssen expand collaboration to develop CDx tests for targeted therapies
The collaboration involves numerous companion diagnostics technologies, including immunohistochemistry, digital pathology, next generation sequencing, PCR, and immunoassays.
February 9, 2023
Bio-Rad, Element Biosciences collaborate on RNA library prep with benchtop sequencer
Bio-Rad will present the results of this collaboration at the Advances in Genome Biology and Technology (AGBT) General Meeting in Hollywood, FL, on Thursday, February 9.
February 8, 2023
Long-COVID subtypes may help stratify patients, inform treatment strategies: Study
January 27, 2023
Foundation Medicine, Natera launch tumor DNA monitoring assay
FoundationOne Tracker may complement imaging to better assess treatment response and inform next steps, particularly when imaging is ambiguous.
January 11, 2023
Agilent Technologies, Akoya Biosciences partner to develop multiplex immunohistochemistry assays for tissue analysis
The firms are collaborating to commercialize end-to-end workflow solutions for tissue biomarker analysis in companion diagnostic development.
January 6, 2023
Blood test could improve detection of potentially fatal pregnancy complication: study
Researchers ran a nested case-control study of 35 cases and 70 controls to find circulating microparticle protein panels that identify pregnancies complicated by placenta accreta spectrum.
January 9, 2023
Page 1 of 5
Next Page
